Related Experiment Video
Updated: Sep 20, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Cardiac-specific troponin-I (cTnI) in a post-mortem setting
Ethan D Sutton1, Sarah Parsons2,3, Maria Pricone4
1Bachelor of Biomedical Science Honours, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Insights
Post-mortem cardiac troponin I (cTnI) testing is often available but highly unstable after death. Interpret results cautiously, especially from decomposed bodies or delayed samples.
Area of Science:
- Forensic Pathology
- Clinical Chemistry
- Biomarker Analysis
Background:
- Cardiac-specific troponin (cTn) aids acute myocardial infarction diagnosis.
- Post-mortem cTn testing has potential but faces limitations.
- Factors influencing post-mortem cTn utility require further investigation.
Purpose of the Study:
- To assess the availability and stability of cardiac-specific Troponin I (cTnI) post-mortem.
- To determine factors affecting post-mortem cTnI test success.
- To evaluate cTnI stability and interpretability in deceased individuals.
Main Methods:
- Analyzed 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples.
- Correlated test success with sample location, type, post-mortem interval, and decomposition.
- Assessed cTnI stability by comparing paired samples from different post-mortem times.
Main Results:
- hs-cTnI tests succeeded in 86.4% of cases; decomposition and extended post-mortem intervals reduced success.
- Visible decomposition precluded successful testing.
- Post-mortem cTnI demonstrated significant instability, with large, erratic variations between samples from the same individual over time.
Conclusions:
- Post-mortem hs-cTnI testing is generally feasible but requires careful sample selection.
- Prioritize earliest available blood samples; avoid testing decomposed individuals.
- Severe post-mortem cTnI instability necessitates cautious interpretation of results.
Abstract:
Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death.Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times.Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret.We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System V: CT

